(CercleFinance.com) – Invest Securities raises its advice on Qiagen shares from ‘neutral’ to ‘buy’, with an unchanged price target of 43 euros.
‘While the T2 publication was not encouraging on various aspects, we are reassured by the T3 publication’, indicates the broker, which mentions results above the guidance and generally in line with its expectations.
‘Unlike its competitors, heavily impacted by the difficult macro context in LifeScience, the group is maintaining its 2023 objectives, with which we are aligned,’ adds the analyst.
Copyright © 2023 CercleFinance.com. All rights reserved.
The information and analyzes distributed by Cercle Finance only constitute a decision-making aid for investors. Cercle Finance cannot be held responsible directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional advisor before making any investment. This indicative information does not in any way constitute an inducement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends using the buttons below.
